Brief: Xspray Pharma Q2 Loss Before Tax Narrows To SEK 28.9 Mln

Xspray Pharma publ AB

05/08/2022 07:32

Aug 5 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * Q2 LOSS BEFORE TAX AMOUNTED TO SEK -28,865 THOUSAND
(-16,952)
    * INTERIM REPORT SECOND QUARTER 2022
    * Q2 CASH FLOW FROM OPERATING ACTIVITIES AMOUNTED TO SEK
-24,472
THOUSAND (-12,831)

Source text for Eikon:  ID:nMFN6xzw9m 
Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))